News

News

  • 06 December 2017

    Bioelectronic medicine is a fast growing alternative to drugs

    Read more
  • 03 May 2017

    The shock tactics set to shake up immunology

    Read more

Portfolio News

  • SetPoint secures $30 Million Series D Equity financing. Funding supports clinical momentum; enables upcoming phase 2 trial in rheumatoid arthritis.

    Read more

    28 August 2017

  • Saluda Medical secures AU$53 Million in D Round funding. Latest funding will support US pivotal clinical trial and global commercialization of Evokeā„¢, the first intelligent, closed-loop spinal cord stimulation system

    Read more

    29 May 2017